Experimental myasthenia: Lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates-Reference-Cited by-同舟云学术

Experimental myasthenia: Lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates

Published:1983-02 Issue:2 Volume:6 Page:160-163
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Hohlfeld Reinhard,Sterz Raimund,Kalies Inge,Wekerle Hartmut,Peper Klaus

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Reference18 articles.

1. Properties of end-plate channels in rats immunized against acetylcholine receptors

2. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: Clinical and electrophysiological aspects

3. The Biology of Myasthenia Gravis

4. Functional Activities of Autoantibodies to Acetylcholine Receptors and the Clinical Severity of Myasthenia Gravis

5. Determination of dose-response curves by quantitative ionophoresis at the frog neuromuscular junction.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I;Clinical Immunology;2009-08

2. Short-circuiting autoimmune disease by target-tissue-derived nitric oxide;Clinical Immunology;2004-10

3. Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis;Clinical Immunology;2003-02

4. Muscle Responds to an Antibody Reactive with the Acetylcholine Receptor by Up-Regulating Monocyte Chemoattractant Protein 1: A Chemokine with the Potential to Influence the Severity and Course of Experimental Myasthenia Gravis;The Journal of Immunology;2002-08-01

5. Myocytes respond in vivo to an antibody reactive with the acetylcholine receptor by upregulating interleukin-15: an interferon-gamma activator with the potential to influence the severity and course of experimental myasthenia gravis;Journal of Neuroimmunology;2001-10